EhtishamMahmudMD
Cardiology • San Diego, CAAdult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Professor of Medicine, UCSD
Dr. Mahmud is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 858-657-8530Fax+1 858-657-8021
Education & Training
University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 1996 - 1999- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1992 - 1995
University of AlbertaClass of 1989
Certifications & Licensure
CA State Medical License 1993 - 2026
GA State Medical License 1999 - 2011- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Brain Radiation Exposure and Attenuation During Invasive Cardiology Procedures Start of enrollment: 2013 Jan 01
- Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions Start of enrollment: 2013 Aug 01
- AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN Start of enrollment: 2013 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 43 citationsProcedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion...Peter Tajti, Khaldoon Alaswad, Dimitri Karmpaliotis, Farouc A. Jaffer, Robert W. Yeh
JACC. Cardiovascular Interventions. 2019-02-25 - 29 citationsElevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention.Lawrence Ang, Omid Behnamfar, Samhita Palakodeti, Felice Lin, Ali Pourdjabbar
Journal of the American Heart Association. 2017-11-18 - 13 citationsMonitoring oral antiplatelet therapy: is it justified?Lawrence Ang, Ehtisham Mahmud
Therapeutic Advances in Cardiovascular Disease. 2008-09-30
Journal Articles
- Percutaneous Coronary Intervention in Acute Coronary SyndromeEhtisham Mahmud, MD, ScienceDirect
Lectures
- Left Main and Bifurcation InterventionsCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
- Driving Quality in PCI: The Benefits of Complete Revascularization for Improvements in Ejection Fraction and Patient Quality of LifeCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
- Complex and High-Risk PCI: A Case Based Joint Symposium by the Society of Cardiovascular Angiography and Interventions and the American College of Cardiology2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Join now to see all
Authored Content
- Management of Acute Myocardial Infarction During the COVID-19 PandemicSeptember 2020
- Chronic Thromboembolic Pulmonary Hypertension Evolving Therapeutic Approaches for Operable and Inoperable DiseaseMay 2018
Press Mentions
CathWorks Announces Key Events for ACC 2023March 2nd, 2023- Society for Cardiovascular Angiography and Interventions Bestows Highest Designation Ranking to LeadMay 1st, 2021
- Consensus Recommendations on AMI Management During COVID-19April 28th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
